Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bismuth Based Quadruple Therapy”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Not applicableLooking for participantsNCT07285096
What this trial is testing

P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

Who this might be right for
Helicobacter Pylori Infection
Yueyue Li 1,730
Not applicableLooking for participantsNCT07165444
What this trial is testing

Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as A Part of Bismuth Based Quadruple Therapy for Treatment of Helicobacter Pylori Infection

Who this might be right for
Potassium-Competitive Acid BlockerProton Pump InhibitorBismuth Based Quadruple Therapy+2 more
Tanta University 320
Not applicableNot Yet RecruitingNCT06340334
What this trial is testing

Efficacy and Safety of Tegoprazan Dual Therapy and Furazolidone-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication: A Prospective, Multicenter, Open-label, Randomized Controlled Clinical Study

Who this might be right for
Helicobacter Pylori InfectionTegoprazanFurazolidone
Nanjing First Hospital, Nanjing Medical University 600
Post-approval studies (Phase 4)Study completedNCT03342456
What this trial is testing

The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers

Who this might be right for
Duodenal Ulcer Due to Helicobacter Pylori
The Third Xiangya Hospital of Central South University 184
Post-approval studies (Phase 4)Study completedNCT00841854
What this trial is testing

Comparison of 7-day and 14-day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication

Who this might be right for
Helicobacter Infection
Asan Medical Center 199
Not applicableStudy completedNCT03431688
What this trial is testing

Tailored Therapy for Clarithromycin-Resistant H. Pylori

Who this might be right for
Helicobacter Pylori Infection
Kangdong Sacred Heart Hospital 782
Post-approval studies (Phase 4)UnknownNCT03299725
What this trial is testing

Bismuth Based Quadruple Therapy 10 Days in Children

Who this might be right for
Helicobacter Pylori Infection
Queen Fabiola Children's University Hospital 120
Not applicableUnknownNCT03361267
What this trial is testing

Comparison of Bismuth Containing Quadruple Therapy and Based Tailored Therapy for H. Pylori Infection

Who this might be right for
Helicobacter Pylori InfectionCompliance, PatientDrug Resistance+1 more
Inha University Hospital 300
Not applicableEnded earlyNCT02359331
What this trial is testing

The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection

Who this might be right for
Helicobacter Infection
Seoul National University Bundang Hospital 370
Not applicableUnknownNCT04674774
What this trial is testing

Efficacy of Tegoprazan Based Bismuth Quadruple Therapy for Helicobacter Pylori Infection

Who this might be right for
Helicobacter Pylori Infection
Incheon St.Mary's Hospital 217
Post-approval studies (Phase 4)Study completedNCT05647278
What this trial is testing

Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1)

Who this might be right for
Helicobacter Pylori Infection
Zhang Xiaofeng,MD 370
Post-approval studies (Phase 4)Study completedNCT01792700
What this trial is testing

Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy

Who this might be right for
Helicobacter Infections
Seoul National University Bundang Hospital 648
Post-approval studies (Phase 4)Study completedNCT02835560
What this trial is testing

Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of Helicobacter Pylori Infection

Who this might be right for
Helicobacter Pylori Eradication Antibiotic
Livzon Pharmaceutical Group Inc. 100
Post-approval studies (Phase 4)Study completedNCT06687499
What this trial is testing

14-day Susceptibility-guided Bismuth Quadruple Therapy for Multiple Drug Resistant H. Pylori Infection

Who this might be right for
Helicobacter PyloriDrug Resistance, Multiple
National Cheng-Kung University Hospital 46
Not applicableUnknownNCT06037122
What this trial is testing

Efficacy of Low-dose Vonoprazan for Helicobacter Pylori Eradication

Who this might be right for
Helicobacter Pylori Infection
Second Affiliated Hospital, School of Medicine, Zhejiang University 558
Not applicableStudy completedNCT03829150
What this trial is testing

Dexlansoprazole MR-Based Concomitant Quadruple Therapy

Who this might be right for
Helicobacter Pylori Infection
Chang Gung Memorial Hospital 202
Post-approval studies (Phase 4)Study completedNCT02935010
What this trial is testing

Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment

Who this might be right for
Helicobacter Pylori Infection
Shanghai Jiao Tong University School of Medicine 382
Not applicableUnknownNCT05097846
What this trial is testing

Differences in the Eradication of Helicobacter Pylori by Different Therapies

Who this might be right for
Helicobacter Pylori Infection
wang xiaoyan 100
Post-approval studies (Phase 4)Enrolling By InvitationNCT04527055
What this trial is testing

The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication

Who this might be right for
Helicobacter Pylori InfectionDysbiosisProbiotics
National Cheng-Kung University Hospital 312
Large-scale testing (Phase 3)Study completedNCT02557932
What this trial is testing

Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication

Who this might be right for
Helicobacter Pylori InfectionFamily History of Stomach Cancer
National Cancer Center, Korea 352
Load More Results